 |
|
Risks of sulfonylurea drugs in the treatment of diabetes mellitus
January 17, 2006Sulfonylurea drugs, used in the treatment of patients with diabetes mellitus to lower blood sugar levels, have been suspected since the 1970s of increasing cardiovascular mortality as well.
In this careful study, some 5800 patients treated with pills for their diabetes were monitored for an average of about 5 years. Patients who were prescribed a sulfonylurea drug (chlorpropamide, tolbutamide or glyburide) experienced higher mortality rates than those who received metformin. Mortality from all causes and deaths attributable to heart attacks were both higher among patients taking sulfonylureas. Patients taking higher doses and those with better prescription compliance were more likely to die than those prescribed lower doses or who took less of their medication.
Canadian Medical Association Journal
Molecular medicine comes to the rescue: Targeted therapy turns life around for child with neonatal diabetes
On Monday, August 14, Lilly Jaffe, a six-year-old North Shore suburban girl who had been diagnosed with type 1 diabetes when she was one month old, checked into the Clinical Research Center at the University of Chicago Medical Center.
More Sulfonylurea Drugs Current Events and Sulfonylurea Drugs News Articles
|
FDA advisory panel recommends muraglitazar for type 2 diabetes: the panel endorsed the drug's use alone and with metformin, but not combined with sulfonylureas.(Endocrinology): ... An article from: Internal Medicine News by Miriam E. Tucker (Author) This digital document is an article from Internal Medicine News, published by Thomson Gale on October 1, 2005. The length of the article is 1254 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: FDA advisory panel recommends muraglitazar for type 2 diabetes: the panel endorsed the drug's use alone and with metformin, but not combined with sulfonylureas.(Endocrinology) Author: Miriam E. Tucker Publication: Internal Medicine News (Magazine/Journal) Date: October 1, 2005 Publisher: Thomson Gale Volume: 38 Issue: 19 Page: 37(1) Distributed by Thomson... | |
|
Beyond sulfonylureas: new oral medications in the treatment of NIDDM (Type II DM).(non-insulin dependent diabetes mellitus or type II diabetes mellitus): An article from: MedSurg Nursing by Theresa Capriotti (Author) This digital document is an article from MedSurg Nursing, published by Jannetti Publications, Inc. on June 1, 1997. The length of the article is 2932 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. From the supplier: Advances in non-insulin dependent diabetes research has led to the creation of a new class of drugs which offer an alternative to the standard sulfonylureas. Drugs such as thiazolidinediones work in the peripheral tissues and can improve sensitivity to insulin. Another trend involves usesulfonylurea in combination with other drugs. Citation Details Title: Beyond sulfonylureas: new... | |
|
Post-MI mortality dip bigger with new sulfonylureas.(myocardial infarction): An article from: Family Practice News by Gale Reference Team (Author) This digital document is an article from Family Practice News, published by Thomson Gale on November 1, 2006. The length of the article is 445 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Post-MI mortality dip bigger with new sulfonylureas.(myocardial infarction) Author: Gale Reference Team Publication: Family Practice News (Magazine/Journal) Date: November 1, 2006 Publisher: Thomson Gale Volume: 36 Issue: 21 Page: 10(1) Distributed by Thomson... | |
|
Sulfonylureas tied to higher mortality after MI.(NEWS)(myocardial infarction)(Report): An article from: Internal Medicine News by Bruce Jancin (Author) This digital document is an article from Internal Medicine News, published by International Medical News Group on October 15, 2009. The length of the article is 448 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Sulfonylureas tied to higher mortality after MI.(NEWS)(myocardial infarction)(Report) Author: Bruce Jancin Publication: Internal Medicine News (Magazine/Journal) Date: October 15, 2009 Publisher: International Medical News Group Volume: 42 Issue: 18 Page: 6(1) Article Type: Report Distributed by Gale, a part of Cengage... | |
|
Oral antidiabetic agents.(Drugs, Pregnancy And Lactation): An article from: Family Practice News by Gerald G. Briggs (Author) This digital document is an article from Family Practice News, published by International Medical News Group on July 15, 2004. The length of the article is 717 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Oral antidiabetic agents.(Drugs, Pregnancy And Lactation) Author: Gerald G. Briggs Publication: Family Practice News (Magazine/Journal) Date: July 15, 2004 Publisher: International Medical News Group Volume: 34 Issue: 14 Page: 27(1) Distributed by Thomson... | |
|
Sulfonylureas can replace insulin use in permanent neonatal diabetes.: An article from: Pediatric News by Kate Johnson (Author) This digital document is an article from Pediatric News, published by Thomson Gale on November 1, 2006. The length of the article is 781 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Sulfonylureas can replace insulin use in permanent neonatal diabetes. Author: Kate Johnson Publication: Pediatric News (Magazine/Journal) Date: November 1, 2006 Publisher: Thomson Gale Volume: 40 Issue: 11 Page: 55(1) Distributed by Thomson... | |
|
Two supplements may benefit diabetic patients.(Endocrinology): An article from: Internal Medicine News by Miriam E. Tucker (Author) This digital document is an article from Internal Medicine News, published by Thomson Gale on October 15, 2005. The length of the article is 808 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Two supplements may benefit diabetic patients.(Endocrinology) Author: Miriam E. Tucker Publication: Internal Medicine News (Magazine/Journal) Date: October 15, 2005 Publisher: Thomson Gale Volume: 38 Issue: 20 Page: 34(1) Distributed by Thomson... |
| © 2009 BrightSurf.com |